malondialdehyde has been researched along with 6,7-dihydroxyflavone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, Y; Liang, F; Ni, W; Wang, B; Wu, N; Xi, H; Xia, D; Zhang, S | 1 |
| Alver, A; Aydin-Abidin, S; Doğramacı, Ş; Erdem, M; Keser, H; Sağlam, N; Şahin, E | 1 |
2 other study(ies) available for malondialdehyde and 6,7-dihydroxyflavone
| Article | Year |
|---|---|
7,8-dihydroxyflavone, a small-molecule tropomyosin-related kinase B (TrkB) agonist, attenuates cerebral ischemia and reperfusion injury in rats.
Topics: Animals; Drug Evaluation, Preclinical; Enzyme Activation; Enzyme Activators; Flavones; Glutathione; Glutathione Peroxidase; Infarction, Middle Cerebral Artery; Male; Malondialdehyde; Nitric Oxide; Oxidative Stress; Rats; Rats, Sprague-Dawley; Receptor, trkB; Reperfusion Injury; Superoxide Dismutase | 2014 |
The TrkB agonist 7,8-dihydroxyflavone improves sensory-motor performance and reduces lipid peroxidation in old mice.
Topics: Aging; Animals; Antioxidants; Behavior, Animal; Flavones; Lipid Peroxidation; Malondialdehyde; Mice; Neurodegenerative Diseases | 2020 |